Cancer News and Research

Latest Cancer News and Research

Roundup: Calif. regulator says insurer's proposed rate hikes are 'unreasonable'; Iowa lawmakers push to deny abortion funding in Medicaid

California Insurance Commissioner Dave Jones said the nation's largest health insurer, UnitedHealth Group Inc., is imposing unreasonable rate hikes on about 5,000 small businesses. Jones said Wednesday that UnitedHealth couldn't justify the average annual increase of nearly 8 percent, which reflects both higher premiums and a reduction in benefits (Terhune, 5/1).

3 May 2013

High costs of cancer drugs may harm patients, say experts

The extremely high prices of recent cancer drugs "may be causing harm to patients," a large group of international leukemia experts warns.

3 May 2013

Loyola takes steps to educate children about sun safety

Having one blistering sunburn in childhood or adolescence more than doubles a person's chance of developing melanoma later in life, yet less than one-third of all young people take the proper steps to protect their skin from excessive sun exposure, according to the Skin Cancer Foundation.

3 May 2013

Emphasizing STD prevention will persuade young women to get HPV vaccine, study suggests

The HPV vaccine can prevent both cervical cancer and a nasty sexually transmitted disease in women.

3 May 2013

Increased accumulation of coronary artery calcium leads to heart attack risk

Patients with increasing accumulations of coronary artery calcium were more than six times more likely to suffer from a heart attack or die from heart disease than patients who didn't have increasing accumulations, according to a recent study published in the Journal of the American College of Cardiology.

3 May 2013

Variations in the sequencing of TERT gene influence risk of breast, ovarian cancers

A major international study involving a Simon Fraser University scientist has found that sequence differences in a gene crucial to the maintenance of our chromosomes' integrity predispose us to certain cancers.

3 May 2013

Measurement variation influences gene expression profiles of breast cancer

An important new study has revealed the clearest picture yet of precisely how much measurement variation influences gene expression profiles of breast cancer.

3 May 2013

Men who take statins are less likely to die from prostate cancer, study finds

Men with prostate cancer who take cholesterol-lowering drugs called statins are significantly less likely to die from their cancer than men who don't take such medication, according to study led by researchers at Fred Hutchinson Cancer Research Center.

3 May 2013

CHOP research offers insights into epilepsy, schizophrenia, other neuropsych disorders

Medical researchers have manipulated human stem cells into producing types of brain cells known to play important roles in neurodevelopmental disorders such as epilepsy, schizophrenia and autism.

3 May 2013

New findings to benefit women with oestrogen-receptor positive breast cancer

A new analysis has provided a comprehensive comparison of scores designed to predict which women with oestrogen-receptor positive breast cancer are at high risk of recurrence beyond five years after diagnosis, and may benefit from prolonged endocrine treatment.

3 May 2013

Cancer Genetics introduces proprietary urogenital cancer array for diagnosing kidney cancer

Cancer Genetics, Inc., a leader in oncology-focused personalized medicine, has launched a proprietary urogenital cancer array, UroGenRA, intended for kidney cancer diagnosis and subtyping in its own laboratory.

3 May 2013

Researchers find association between DCIS Score and risk of developing IBE

The ductal carcinoma in situ Score quantifies the risk of ipsilateral breast event and invasive IBE risk, complements both traditional clinical and pathologic factors, and helps provide a new clinical tool to improve the process of selecting individualized treatment for women with DCIS who meet the criteria, according to a study published May 2 in the Journal of the National Cancer Institute.

3 May 2013

Research findings suggest new treatment for breast, colon, melanoma and other cancers

A common cancer pathway causing tumor growth is now being targeted by a number of new cancer drugs and shows promising results.

3 May 2013

Better individual risk prediction for women with breast cancer is getting nearer, says study author

A test that measures the expression levels of 58 genes in oestrogen receptor-positive breast cancers can effectively differentiate between patients who are at higher and lower risk for having their cancer recur elsewhere in the body more than five years after diagnosis, researchers report.

3 May 2013

Synthetic anti-inflammatory substances related to marijuana may help fight HIV infection

HIV, the virus that causes AIDS, is notorious for hiding within certain types of cells, where it reproduces at a slowed rate and eventually gives rise to chronic inflammation, despite drug therapy.

2 May 2013

Study may help diagnose endometrial cancer and lead to new drug development

Endometrial tumors can be reclassified into distinct subtypes based partly on their genomic makeup and may respond to targeted drugs already being tested in clinical trials, according to a large-scale genomic analysis led by researchers at Memorial Sloan-Kettering Cancer Center and other centers within The Cancer Genome Atlas (TCGA) Research Network.

2 May 2013

Powerful data-sifting algorithms help untangle complex genetics of cancer

Powerful data-sifting algorithms developed by computer scientists at Brown University are helping to untangle the profoundly complex genetics of cancer.

2 May 2013

Study brings opportunities of personalised therapy for breast cancer a step closer

A study led by prominent breast cancer experts from Europe and the US has revealed a number of potentially important prospects for targeted therapies, and brings opportunities of truly personalised therapy for breast cancer a step closer, researchers said at the 5th IMPAKT Breast Cancer Conference in Brussels, Belgium.

2 May 2013

Prosigna Breast Cancer Prognostic Gene Signature Assay predicts ROR in women with early-stage breast cancer

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and molecular diagnostic products, today announced results from two studies that are featured in oral presentations this week at IMPAKT Breast Cancer Conference.

2 May 2013

EventusDx receives CE mark designation for Octava Pink breast cancer test

Eventus Diagnostics, Inc. today announced that it has received CE mark designation for its Octava Pink™ breast cancer test intended for confirmatory use in women who have received negative mammography results.

2 May 2013

Cancer News and Research

Latest Cancer News and Research

Roundup: Calif. regulator says insurer's proposed rate hikes are 'unreasonable'; Iowa lawmakers push to deny abortion funding in Medicaid

High costs of cancer drugs may harm patients, say experts

Loyola takes steps to educate children about sun safety

Emphasizing STD prevention will persuade young women to get HPV vaccine, study suggests

Increased accumulation of coronary artery calcium leads to heart attack risk

Variations in the sequencing of TERT gene influence risk of breast, ovarian cancers

Measurement variation influences gene expression profiles of breast cancer

Men who take statins are less likely to die from prostate cancer, study finds

CHOP research offers insights into epilepsy, schizophrenia, other neuropsych disorders

New findings to benefit women with oestrogen-receptor positive breast cancer

Cancer Genetics introduces proprietary urogenital cancer array for diagnosing kidney cancer

Researchers find association between DCIS Score and risk of developing IBE

Research findings suggest new treatment for breast, colon, melanoma and other cancers

Better individual risk prediction for women with breast cancer is getting nearer, says study author

Synthetic anti-inflammatory substances related to marijuana may help fight HIV infection

Study may help diagnose endometrial cancer and lead to new drug development

Powerful data-sifting algorithms help untangle complex genetics of cancer

Study brings opportunities of personalised therapy for breast cancer a step closer

Prosigna Breast Cancer Prognostic Gene Signature Assay predicts ROR in women with early-stage breast cancer

EventusDx receives CE mark designation for Octava Pink breast cancer test

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in